These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8810320)

  • 1. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein.
    Levy AP; Levy NS; Goldberg MA
    J Biol Chem; 1996 Oct; 271(41):25492-7. PubMed ID: 8810320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
    Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
    Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene.
    Levy AP; Levy NS; Iliopoulos O; Jiang C; Kaplin WG; Goldberg MA
    Kidney Int; 1997 Feb; 51(2):575-8. PubMed ID: 9027742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Marti HH; Plate KH
    Blood; 1998 Nov; 92(9):3388-93. PubMed ID: 9787178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C; Moore JW; Robertson N; Harris AL
    Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.
    Mukhopadhyay D; Knebelmann B; Cohen HT; Ananth S; Sukhatme VP
    Mol Cell Biol; 1997 Sep; 17(9):5629-39. PubMed ID: 9271438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
    Iliopoulos O; Levy AP; Jiang C; Kaelin WG; Goldberg MA
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10595-9. PubMed ID: 8855223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
    Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
    J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.
    Siemeister G; Weindel K; Mohrs K; Barleon B; Martiny-Baron G; Marmé D
    Cancer Res; 1996 May; 56(10):2299-301. PubMed ID: 8625303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Elongin BC complex and the von Hippel-Lindau tumor suppressor protein.
    Conaway JW; Kamura T; Conaway RC
    Biochim Biophys Acta; 1998 Apr; 1377(2):M49-54. PubMed ID: 9606976
    [No Abstract]   [Full Text] [Related]  

  • 12. Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity.
    Blankenship C; Naglich JG; Whaley JM; Seizinger B; Kley N
    Oncogene; 1999 Feb; 18(8):1529-35. PubMed ID: 10102622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation.
    Iliopoulos O; Ohh M; Kaelin WG
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11661-6. PubMed ID: 9751722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of von Hippel-Lindau disease.
    Iliopoulos O; Kaelin WG
    Mol Med; 1997 May; 3(5):289-93. PubMed ID: 9205944
    [No Abstract]   [Full Text] [Related]  

  • 15. von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis.
    Jones MK; Szabó IL; Kawanaka H; Husain SS; Tarnawski AS
    FASEB J; 2002 Feb; 16(2):264-6. PubMed ID: 11772947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
    Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
    Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes.
    Stein I; Neeman M; Shweiki D; Itin A; Keshet E
    Mol Cell Biol; 1995 Oct; 15(10):5363-8. PubMed ID: 7565686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability.
    Claffey KP; Shih SC; Mullen A; Dziennis S; Cusick JL; Abrams KR; Lee SW; Detmar M
    Mol Biol Cell; 1998 Feb; 9(2):469-81. PubMed ID: 9450968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor.
    Baba M; Hirai S; Yamada-Okabe H; Hamada K; Tabuchi H; Kobayashi K; Kondo K; Yoshida M; Yamashita A; Kishida T; Nakaigawa N; Nagashima Y; Kubota Y; Yao M; Ohno S
    Oncogene; 2003 May; 22(18):2728-38. PubMed ID: 12743597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L.
    Shih SC; Claffey KP
    J Biol Chem; 1999 Jan; 274(3):1359-65. PubMed ID: 9880507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.